Rheumatoid arthritis: International disparities in access to anti-TNF therapy.
Nat Rev Rheumatol 7(4):197-8 (2011) PMID 21455248
The establishment of new benchmarks for treatment outcomes promises to drive great advances in rheumatoid arthritis therapy, but data on ‘real life’ experience with biologic therapy demonstrate that geographic location influences the stage of disease at which these agents are initiated.
DOI: 10.1038/nrrheum.2011.27
Version: za2963e q8zab q8zbe q8zc9 q8zd1 q8zed q8zf1 q8zg3